Vaccitech Statistics
Share Statistics
Vaccitech has 38.55M
shares outstanding. The number of shares has increased by 0%
in one year.
| Shares Outstanding | 38.55M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 6,675 |
| FTD / Avg. Volume | 0.91% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 16.39 and the forward
PE ratio is null.
Vaccitech's PEG ratio is
-0.15.
| PE Ratio | 16.39 |
| Forward PE | n/a |
| PS Ratio | 1.96 |
| Forward PS | n/a |
| PB Ratio | 0.36 |
| P/FCF Ratio | -4.26 |
| PEG Ratio | -0.15 |
Financial Ratio HistoryEnterprise Valuation
Vaccitech has an Enterprise Value (EV) of -98.08M.
| EV / Sales | -2.19 |
| EV / EBITDA | -112.86 |
| EV / EBIT | 6.8 |
| EV / FCF | 4.77 |
Financial Position
The company has a current ratio of 17.4,
with a Debt / Equity ratio of 0.04.
| Current Ratio | 17.4 |
| Quick Ratio | 17.4 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 10.1 |
| Debt / FCF | -0.43 |
| Interest Coverage | -181.79 |
Financial Efficiency
Return on Equity is 2.2% and Return on Invested Capital is -8.59%.
| Return on Equity | 2.2% |
| Return on Assets | 1.98% |
| Return on Invested Capital | -8.59% |
| Revenue Per Employee | $1,354,636.36 |
| Profits Per Employee | $161,878.79 |
| Employee Count | 33 |
| Asset Turnover | 0.17 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -4.47M |
| Effective Tax Rate | -526% |
Stock Price Statistics
The stock price has increased by 58.73% in the
last 52 weeks. The beta is -0.27, so Vaccitech's
price volatility has been lower than the market average.
| Beta | -0.27 |
| 52-Week Price Change | 58.73% |
| 50-Day Moving Average | 3.35 |
| 200-Day Moving Average | 2.6 |
| Relative Strength Index (RSI) | 49.91 |
| Average Volume (20 Days) | 731,881 |
Income Statement
In the last 12 months, Vaccitech had revenue of 44.7M
and earned 5.34M
in profits. Earnings per share was 0.14.
| Revenue | 44.7M |
| Gross Profit | 2.35M |
| Operating Income | -3.45M |
| Net Income | 5.34M |
| EBITDA | 869K |
| EBIT | 869K |
| Earnings Per Share (EPS) | 0.14 |
Full Income StatementBalance Sheet
The company has 194.38M in cash and 8.77M in
debt, giving a net cash position of 185.61M.
| Cash & Cash Equivalents | 194.38M |
| Total Debt | 8.77M |
| Net Cash | 185.61M |
| Retained Earnings | -103.24M |
| Total Assets | 229.97M |
| Working Capital | 152.5M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -14.43M
and capital expenditures -6.14M, giving a free cash flow of -20.57M.
| Operating Cash Flow | -14.43M |
| Capital Expenditures | -6.14M |
| Free Cash Flow | -20.57M |
| FCF Per Share | -0.55 |
Full Cash Flow StatementMargins
Gross margin is 5.26%, with operating and profit margins of -7.73% and 11.95%.
| Gross Margin | 5.26% |
| Operating Margin | -7.73% |
| Pretax Margin | 1.9% |
| Profit Margin | 11.95% |
| EBITDA Margin | 1.94% |
| EBIT Margin | -7.73% |
| FCF Margin | -46.01% |
